News

Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million
Gilead will supply lenacapavir to Global Fund countries for HIV prevention, but questions remain amid PEPFAR cuts and funding ...
Mirage News4h
Clinical Trials Uncover Safer Alternatives for TB Drug
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with ...
Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...
Medical Dialogues18h
New credit card-sized TB test could close the diagnostic gap in HIV hotspots: Study
Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...
ET HealthWorld18h
Three COVID-19 patients die in Indore in 48 hours; no need to panic, says official
Three women diagnosed with COVID-19 died in Indore over a 48-hour period, but health officials urge the public not to panic, ...